PHARMSOL NEWS ISSUE NO. 3

31 July, 2022 8:00 am

Container Closure System Selection Criteria: Critical Quality Attribute For Non-Sterile Drug Products

31 May, 2022 12:00 am

Successful EU GMP Certification of Shandong Xinhua Pharmaceutical Co. Ltd supported by Team PharmSol

30 May, 2022 12:00 am

Effervescent Tablets; Practical and Convenient Delivery System For Drug Administration

30 March, 2022 12:00 am

Transdermal Drug Delivery System (TDDS)

30 January, 2022 12:00 am

Formulation Development using Soft Gelatin-Based Technology

30 November, 2021 12:00 am

EU GMP Success of Jiangsu Hansoh Pharmaceutical Group Co Ltd with the support of PharmSol

30 November, 2021 12:00 am

Orodispersible Films – Emerging and Patient Centric Drug Delivery System

30 September, 2021 12:00 am

Dry Powder Inhalers – A preferred form of inhalation therapeutic segment for respiratory diseases

30 July, 2021 12:00 am

MUPS – A Promising & Flexible Controlled Drug Delivery System

30 May, 2021 12:00 am

Excipients: From an auxiliary substance to game changer in Drug Delivery

30 December, 2020 12:00 am

Hot Melt Technology – Novel Solvent Free Approach

25 November, 2020 12:00 am

EU Regulatory requirement on Falsified Medicine Directive (FMD)

14 February, 2020 12:00 am

EU GMP Success of Finoso Pharma Private Ltd. with the support of PharmSol

14 October, 2020 12:00 am

ARE YOU BREXIT READY?

14 October, 2020 12:00 am

PharmSol is proud to be associated with Eskayef in EU GMP Success

21 July, 2020 12:00 am

Navigating Regulatory Requirements for Drug Substances

7 July, 2020 12:00 am

Drug Substances – Managing Risks

14 June, 2020 12:00 am

The Future of Pharmaceutical Contract Development

11 May, 2020 12:00 am

Challenges in the EUGMP Inspection of Sterile Facility

23 April, 2020 12:00 am

Realignment in Drug Substances – POST COVID 19

8 April, 2020 12:00 am

A Perspective on Changing Regulatory Landscape in China Pharma Industry

13 February, 2020 12:00 am

PharmSol Team Message

3 October, 2019 12:00 am

EU GMP Certification of Jiangsu Hansoh Pharmaceutical Co. Ltd. supported by PharmSol Group

15 June, 2019 12:00 am

EU GMP Certification of Shouguang Fukang Pharmaceutical Ltd. supported by PharmSol Group

20 August, 2019 12:00 am

EU GMP Certification of Beximco Pharmaceuticals Ltd. supported by PharmSol Group

14 August, 2019 12:00 am

EU GMP CERTIFICATION OF SRI KRISHNA PHARMACEUTICALS LTD. (SKPL) SUPPORTED BY PHARMSOL GROUP

18 April, 2019 12:00 am

EU GMP CERTIFICATION OF UNISON PHARMACEUTICAL PVT LTD SUPPORTED BY PHARMSOL GROUP

28 October, 2019 12:30 am

PHARMSOL NEWS ISSUE NO. 5

14 October, 2019 12:15 am

PHARMSOL NEWS ISSUE NO. 4

18 April, 2019 12:00 am

We are delighted to announce the opening of our new office located at Nanjing, China

8 March, 2018 12:00 am

EU GMP Certification of Anqui Lu’An Pharmaceutical Co. Ltd. supported by PharmSol Group

22 November, 2017 12:00 am

EU GMP Certification of Sri Krishna Pharmaceuticals Ltd. (SKPL) supported by PharmSol Group

22 November, 2017 12:00 am

EU GMP Certification of Shouguang Fukang Pharmaceutical Co. Ltd. supported by PharmSol Group

1 February, 2018 8:00 am

PharmSol News Issue No. 1

1 March, 2018 12:00 am

PharmSol News Issue No. 2

15 January, 2017 12:00 am

EU GMP Certification of Galpha Baddi supported by PharmSol Group

19 January, 2017 12:00 am

Changzhou Yabang and PharmSol Group Strategic Alliance

22 January, 2017 12:00 am

Strategic Cooperation – Jiangsu Hansoh and PharmSol Group

26 June, 2016 12:00 am

PharmSol conducts CEIV Pharma Audit at Changi Airport (SIN)

12 October, 2016 12:00 am

DNATA, Dubai, CEIV Pharma Audit by PharmSol

7 November, 2016 12:00 am

Sinopharm Zhijun & PharmSol – Strategic Cooperation Agreement for Co-development of Products

16 November, 2016 12:00 am

PharmSol’s Presence at CEIV Pharma Audit, Hong Kong

18 August, 2016 12:00 am

Training Program at Medicines Authority, Malta

18 May, 2016 12:00 am

We are delighted to announce the opening of our new office located at Zhuhai, China

15 March, 2016 12:00 am